Outcome
Type |
Measure |
Description |
Time frame |
Safety issue |
Primary |
determination of limb volume changes |
The circumference measurements for lymphedema will be calculated using the Frustum formula. calculations will compare with operated and non-operated limb, and also subsequent measurements. A volume increase of >200 ml is interpreted as the onset of lymphedema. |
postoperative to 3 months later |
|
Primary |
determination of shoulder and upper extremity functions |
Modified Constant Murley Score for assessment of shoulder and upper extremity functions. high score indicates good function. |
postoperative to 3 months later |
|
Primary |
muscle shortness test |
Pectoralis major and pectoralis minor muscle shortness tests.measurements will compare with operated and non-operated limb, and also subsequent. |
postoperative to 3 months later |
|
Primary |
Bioimpedance analysis for body composition determination; weight |
Tanita bioimpedance analysis device will be used to determine body composition. Measurements will be compared with the subsequent. bioimpedance analysis determines that; body weight (kg), muscle mass (kg), estimated bone ratio (kg). |
postoperative to 3 months later |
|
Primary |
Bioimpedance analysis for body composition determination;body mass index |
Tanita bioimpedance analysis device will be used to determine body composition. Measurements will be compared with the subsequent. bioimpedance analysis determines that; body mass index (kg/m2). |
postoperative to 3 months later |
|
Primary |
Bioimpedance analysis for body composition determination; body fat and water percentage |
Tanita bioimpedance analysis device will be used to determine body composition. Measurements will be compared with the subsequent. bioimpedance analysis determines that; body fat percentage, body water percentage. |
postoperative to 3 months later |
|
Primary |
Bioimpedance analysis for body composition determination; visceral fat level |
Tanita bioimpedance analysis device will be used to determine body composition. Measurements will be compared with the subsequent. bioimpedance analysis determines that; visceral fat level. |
postoperative to 3 months later |
|
Primary |
Bioimpedance analysis for body composition determination; energy consumption |
Tanita bioimpedance analysis device will be used to determine body composition. Measurements will be compared with the subsequent. bioimpedance analysis determines that; total daily energy consumption (kcal/day). |
postoperative to 3 months later |
|
Primary |
Bioimpedance analysis for body composition determination; metabolic age |
Tanita bioimpedance analysis device will be used to determine body composition. Measurements will be compared with the subsequent. bioimpedance analysis determines that; metabolic age (years). |
postoperative to 3 months later |
|
Primary |
determination of subdermal fluid ratio |
Moisturemeter compactD for measurement of subdermal fluid ratio. Measurements will be compared with the subsequent. |
postoperative to 3 months later |
|
Primary |
assesment of fatigue |
Cancer Fatigue Scale for assesment of fatigue. A low score indicates a low fatigue rate. |
postoperative to 3 months later |
|
Primary |
determination of cardiovascular endurance |
6 Minute Walk Test (6MWT) will be used for cardiovascular endurance.Changes of >35 m are significant changes. |
postoperative to 3 months later |
|
Secondary |
determination of emotional status |
It is expected that the psychosocial functions that have decreased due to breast cancer will be restored in a short time with physiotherapy follow-up and improvement of physical functions. Hospital Anxiety and Depression Scale (HAD) will be used for psychosocial status. A low score indicates low anxiety and depression. |
baseline to 3 months later |
|
Secondary |
Determination of quality of life |
Functional Assessment of Cancer Therapy -Breast Cancer (FACT-B) scale for assessment of functional status and activities of daily living. high score indicates good function. |
postoperative to 3 months later |
|